ClinicalTrials.gg
RecruitingNCT07945197Updated Nov 18, 2026

Efficacy of Automated Tuina and Acupuncture for Treating Chronic Lower Back Pain

An interventional study of Acupuncture and automated robotic Tuina and Acupuncture alone in Chronic Nonspecific Low Back Pain, sponsored by Nanyang Technological University. Recruiting at 2 sites in Singapore. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Nanyang Technological University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jan 2025, registered Oct 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if adding automated robotic Tuina to acupuncture yields a better outcome than acupuncture alone in treating adults with chronic nonspecific low back pain. It will also learn about the safety of the automated robotic Tuina. The main questions it aims to answer are:

Does robotic Tuina and acupuncture reduces score of Visual Analogue Scale (VAS) more than acupuncture alone? Does it improve the sleep, quality of life, pain related impact of participants? Researchers will compare automated robotic Tuina and acupuncture to acupuncture alone if the combination works better to treat chronic nonspecific low back pain.

Participants will:

Receive weekly treatment of either automated robotic Tuina and acupuncture or acupuncture only for 6 sessions over 8 weeks.

Visit the clinic weekly for interventions and test. Wear a sleep tracker ring on the night before and night of treatment to sleep.

Read the detailed description

Chronic nonspecific low back pain is a common condition that can affect daily activities and quality of life. Tuina is a traditional Chinese medicine manual therapy that may help relieve pain and improve function. Automated robotic Tuina may offer a more standardized approach to delivering this treatment.

This randomized controlled study aims to evaluate whether adding automated robotic Tuina to acupuncture provides additional benefits for adults with chronic nonspecific low back pain, compared with acupuncture alone.

A total of 56 participants aged 21 to 70 years are planned for recruitment across three study sites in Singapore. Participants will be randomly assigned in a 1:1 ratio to receive either acupuncture alone or acupuncture combined with automated robotic Tuina.

The primary outcome is low back pain intensity measured using a visual analogue scale (VAS). Secondary outcomes include physical disability, pain-related interference, quality of life, sleep-related measures and acceptance of robotic Tuina. Adverse events will also be monitored throughout the study.

The findings may help clarify the additional clinical benefit and safety of automated robotic Tuina when used alongside acupuncture for chronic nonspecific low back pain.

02

Conditions studied

  • Chronic Nonspecific Low Back Pain

Browse trials for

Keywords

  • chronic low back pain
  • acupuncture
  • robotic Tuina
03

In context

Low Back Pain

2,929 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 56 is close to the median of 60 across 2,368 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Nanyang Technological University is the lead sponsor of 54 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 21 to 70 years.
  • At least one primary care visit for back pain within the past 3 to 12 months at either a Chinese medicine or Western medicine clinic.
  • Non-specific, uncomplicated low back pain, as specified in the study protocol.
  • Able to communicate and write in English and/or Chinese.

Exclusion criteria

Exclusion Criteria:

  • Previous acupuncture for back pain within the past 3 months.
  • Low back pain lasting less than 3 months.
  • Mild symptoms, defined in the protocol as a score below 5 on a 0 to 10 pain bothersomeness scale.
  • Specific diseases or pathologies identified as the cause of back pain, including the conditions listed in the study protocol.
  • Previous vertebral column or back surgery.
  • Disabling chronic conditions that may confound treatment effects or interpretation of the data.
  • to acupuncture or situations in which its safety has not been confirmed, including clotting disorders, anticoagulant therapy, a cardiac pacemaker, pregnancy or seizure disorder.
  • Deemed unfit for acupuncture and/or robotic Tuina by the treating Chinese medicine physician because of the participant's current medical condition.
  • Current use of long-term medication for pain management and relief, as specified in the study protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Acupuncture Plus Automated Robotic Tuina

    Standard acupuncture treatment followed by Automated Robotic Tuina

    Other: Acupuncture and automated robotic Tuina

  • Active comparator
    Acupuncture alone

    Standard acupuncture

    Other: Acupuncture alone

Interventions

  • OtherAcupuncture and automated robotic Tuina

    Participants receive 30 minute standard acupuncture and automated robotic Tuina using the EMMA device, according to the study's standardized operating procedures. Robotic Tuina is applied to the lumbosacral region, hips and lower limbs. The protocol describes an approximately 30-minute robotic Tuina treatment, with the applied force adjusted according to participant feedback within the specified range.

  • OtherAcupuncture alone

    Participants receive acupuncture according to the study's standardized treatment protocol. The protocol describes needle retention for 30 minutes and specifies the acupuncture points and procedures to be used.

06

What researchers measure

Primary outcomes

  1. Change from baseline in pain intensity. Visual analogue scale.

    A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

    Time frame: At baseline, at 8 weeks

Secondary outcomes

  1. Change from baseline in Roland Morris Disability Questionnaire (RMDQ).

    This is a self-reported questionnaire consisting in 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, vending over, sitting, lying down, dressing, sleeping, self-care and daily activities.

    Time frame: At baseline and at 8 weeks

  2. Change from baseline in Brief Pain Inventory (BPI)

    Pain interference was evaluated using the Pain Interference subscale of the Brief Pain Inventory (BPI). The subscale consists of 7 items assessing how much pain disrupts dimensions of daily living. Each item is scored on a 0 to 10 numeric rating scale. The overall score is calculated as the mean of the 7 items, yielding a final score ranging from a minimum of 0 to a maximum of 10. A higher score indicates a worse outcome (greater pain interference with daily functioning).

    Time frame: At baseline and at 8 weeks

  3. Change from baseline in WHO-QOL (Brief)

    Quality of life was evaluated using the World Health Organization Quality of Life-BREF (WHOQOL-BREF). The scale comprises 26 items assessing 4 domains: Physical Health (7 items), Psychological (6 items), Social Relationships (3 items), and Environment (8 items). Domain scores are calculated by summing the respective items and converting them to a transformed scale. For each domain, scores range from a minimum of 0 to a maximum of 100, where a higher score indicates a better outcome (higher quality of life)

    Time frame: At baseline and at 8 weeks

  4. Change in objective sleep parameters via wearable smart ring

    Assessed using Leadtek smart ring worn on the finger. Evaluated parameters include sleep time, overnight heart rate variability and sleep quality from baseline to week 8

    Time frame: At baseline throughout the 8 weeks, to be tracked the night before and after treatment session.

  5. Change in Technology Acceptance Model (TAM) questionnaire from baseline

    Participant acceptance of automated robotic Tuina, will be measured at baseline and after completion of study covering domains including perceieved usefulness, attitude and behavioural intentions. A 7-point Likert scale was used to measure TAM constructs, where 1 indicated 'strongly disagree' and 7 indicated ' strongly agree'. A higher score reflects better perception of and attitutude towards the technology.

    Time frame: At baseline and at 8 weeks

  6. Incidence of Treatment-Emergent Adverse Events [Safety]

    Incidence and nature of adverse events during the study.

    Time frame: From start of treatment to end of treatment at week 8

07

Study locations

2 of 2 sites recruiting
  • Novahealth TCM Clinic
    Singapore, 229469, Singapore
    Recruiting
    • Chin Ee Ho · Contact+65 84130628
  • NTU Chinese Medicine Clinic
    Singapore, 637551, Singapore
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be made available to external researchers. Participant-level data contain confidential health information and will be managed in accordance with the approved study protocol, informed consent requirements, institutional policies and applicable data-protection requirements. Study findings will be disseminated through appropriate scientific publications and other research outputs.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2027, 35 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 35 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2026
First posted
Nov 18, 2026
StartActual
Jan 1, 2025
Primary completionEst.
Dec 30, 2027
CompletionEst.
Dec 30, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945197
Lead sponsor
Nanyang Technological University
Collaborators
Singapore University of Social Sciences
Responsible party
Linda Zhong (Associate Professor, Nanyang Technological University) — Principal investigator
First posted
Nov 18, 2026
Start date
Jan 1, 2025
Primary completion
Dec 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Linda Zhong
Contact
linda.zhong@ntu.edu.sg
+65 6592 1733
Chin Ee Ho
Contact
chinee001@e.ntu.edu.sg
+65 84130628
Linda Zhong, Associate Professor
principal investigator · Nanyang Technological University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion